The Treatment of Depression With Botulinum Type A Toxin
Phase 2
Completed
- Conditions
- Depression
- Interventions
- Drug: botulinum toxin type A neurotoxin complexDrug: Placebo
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Seton Healthcare Family
- Target Recruit Count
- 30
- Registration Number
- NCT01392963
- Locations
- 🇺🇸
Seton Mind Institute: Medical Park Tower, Austin, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath